Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgery and Re-Irradiation for Recurrent Ependymoma
NCT02125786Phase 2Active, not recruiting
- Sponsor
- St. Jude Children's Research Hospital
- Start
- May 2014
- Primary completion
- May 2023
- Countries
- 1
01
Overview
Phase 2, open-label trial in ependymoma (4 arms), sponsored by St. Jude Children's Research Hospital. Primary endpoints: Progression-free Survival Rate at 3 years and Overall Survival Rate at 3 years. Started May 2014; status: active, not recruiting.
02
Conditions
ependymoma
Beyond the preview
Go deeper on NCT02125786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02125786.